Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 4,897Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 10Sutent

PharmaCompass

01

Brand Name : Sutent

Sunitinib Malate

arrow
BIO Asia-Taiwan
Not Confirmed

Brand Name : Sutent

arrow
BIO Asia-Taiwan
Not Confirmed

Sunitinib Malate

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 936

2018 Revenue in Millions : 1,049

Growth (%) : -11

blank

02

Brand Name : Sutent

Sunitinib Malate

arrow
BIO Asia-Taiwan
Not Confirmed

Brand Name : Sutent

arrow
BIO Asia-Taiwan
Not Confirmed

Sunitinib Malate

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 819

2019 Revenue in Millions : 936

Growth (%) : -13

blank

03

Brand Name : Sutent

Sunitinib Malate

arrow
BIO Asia-Taiwan
Not Confirmed

Brand Name : Sutent

arrow
BIO Asia-Taiwan
Not Confirmed

Sunitinib Malate

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 673

2020 Revenue in Millions : 819

Growth (%) : -18

blank

04

Brand Name : Sutent

Sunitinib Malate

arrow
BIO Asia-Taiwan
Not Confirmed

Brand Name : Sutent

arrow
BIO Asia-Taiwan
Not Confirmed

Sunitinib Malate

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 347

2021 Revenue in Millions : 673

Growth (%) : -48

blank

05

Brand Name : Sutent

Sunitinib Malate

arrow
BIO Asia-Taiwan
Not Confirmed

Brand Name : Sutent

arrow
BIO Asia-Taiwan
Not Confirmed

Sunitinib Malate

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 180

2022 Revenue in Millions : 347

Growth (%) : -48

blank

06

Brand Name : Sutent

Sunitinib Malate

arrow
BIO Asia-Taiwan
Not Confirmed

07

Brand Name : Sutent

Sunitinib Malate

arrow
BIO Asia-Taiwan
Not Confirmed

Brand Name : Sutent

arrow
BIO Asia-Taiwan
Not Confirmed

Sunitinib Malate

Main Therapeutic Indication : Oncology

Currency : USD

2015 Revenue in Millions : 1,174

2014 Revenue in Millions : 1,120

Growth (%) : -5%

blank

08

Brand Name : Sutent

Sunitinib Malate

arrow
BIO Asia-Taiwan
Not Confirmed

Brand Name : Sutent

arrow
BIO Asia-Taiwan
Not Confirmed

Sunitinib Malate

Main Therapeutic Indication : Oncology

Currency : USD

2016 Revenue in Millions : 1,095

2015 Revenue in Millions : 1,120

Growth (%) : -2

blank

09

Brand Name : Sutent

Sunitinib Malate

arrow
BIO Asia-Taiwan
Not Confirmed

Brand Name : Sutent

arrow
BIO Asia-Taiwan
Not Confirmed

Sunitinib Malate

Main Therapeutic Indication : Oncology

Currency : USD

2017 Revenue in Millions : 1,081

2016 Revenue in Millions : 1,096

Growth (%) : -1

blank

10

Brand Name : Sutent

Sunitinib Malate

arrow
BIO Asia-Taiwan
Not Confirmed

Brand Name : Sutent

arrow
BIO Asia-Taiwan
Not Confirmed

Sunitinib Malate

Main Therapeutic Indication : Oncology

Currency : USD

2018 Revenue in Millions : 1,049

2017 Revenue in Millions : 1,081

Growth (%) : -3%

blank